CLINICAL_TRIALS
trial_result
· 2022-09-19
Clinical Trial Update: Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines [Phase 3]
Summary
Phase 3 trial investigating elective level Ib irradiation in nasopharyngeal carcinoma following international guidelines.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fujian Cancer Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN